Brief Intervention for Self-Harm in Veterans

(STRIVe Trial)

Recruiting in Palo Alto (17 mi)

Overseen by Tate F Halverson, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: VA Office of Research and Development

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing a therapy called T-SIB to help Veterans who hurt themselves on purpose. The therapy teaches healthier ways to cope and uses real-time tracking to understand and manage triggers. Veterans are targeted because they have higher rates of self-injury, which can lead to serious mental health problems.

Research Team

Tate F Halverson, PhD

Principal Investigator

Durham VA Medical Center, Durham, NC

Eligibility Criteria

This trial is for Veterans aged 18 or older who have harmed themselves on purpose at least twice in the past month without suicidal intent. Participants must be fluent in English and able to consent to the study. Those with a history of psychosis, mania, hypomania, or current high risk of suicide or homicide are not eligible.

Inclusion Criteria

I am 18 years old or older.

Fluent in English

Past service in the United States military

Exclusion Criteria

I cannot or do not want to follow the study's required procedures.

Lifetime history of psychosis, mania, or hypomania

Imminent risk for suicide/homicide warranting immediate intervention

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive nine sessions of Treatment for Self-Injurious Behaviors (T-SIB) to reduce NSSI and improve psychosocial functioning

9 weeks

9 sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Treatment As Usual (Other)
• Treatment for Self-Injurious Behaviors (Behavioral Intervention)

Trial Overview The study is testing a brief intervention designed to reduce self-harm behaviors and improve psychosocial functioning among Veterans. It will compare this new approach against the usual treatment methods typically offered for self-injury.

Participant Groups

Group I: T-SIB Experimental Treatment 1 Intervention

Participants randomized to the Treatment for Self-Injurious Behaviors (T-SIB) condition will receive nine sessions of T-SIB.

Group II: Treatment As Usual Active Control 1 Intervention

Participants randomized to the TAU condition will be provided with referrals to both Durham VA and local community mental health resources and offered a consult for Durham VA mental health services.

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials

1,691

Recruited

3,759,000+

Dr. Grant Huang

VA Office of Research and Development

Acting Chief Research and Development Officer

PhD in Medical Psychology and Master of Public Health from the Uniformed Services University of Health Sciences

Dr. Erica M. Scavella

VA Office of Research and Development

Chief Medical Officer since 2022

MD from University of Massachusetts School of Medicine